BioCentury
ARTICLE | Financial News

Celldex completes follow-on

February 11, 2013 8:00 AM UTC

Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass. Business: Cancer, Infectious, Renal Date completed: 2/5/13 Type: Follow-on Raised: $103.5 million Shares: 13.8 million Price: $7.50 Shares after...